Vitiligo Gets Long-Missing Definitions for Severity and Relapse - Takeaways - MDSpire

Vitiligo Gets Long-Missing Definitions for Severity and Relapse

A new international consensus framework standardizes how disease severity and relapse are defined, addressing inconsistencies that have complicated clinical trials and treatment decisions.

  • By

  • Kerri Miller

  • April 15, 2026

  • 2 min

Share

  • 1

    Vitiligo lacks standardized definitions of severity and relapse, complicating treatment strategies and patient management.

  • 2

    Recent therapeutic advances, including JAK inhibitors, have not been adequately assessed for relapse due to inconsistent definitions.

  • 3

    An international consensus statement aims to establish body surface area-based severity strata and define relapse more clearly.

  • 4

    The new framework represents a shift towards multidimensional assessments, incorporating both psychological and clinical factors.

  • 5

    Applying the consensus criteria consistently in clinical trials and practice is the next challenge for managing vitiligo.

Original Source(s)

Vitiligo Gets Long-Missing Definitions for Severity and Relapse

  • by Kerri Miller

  • April 15, 2026

Related Content

Cupping vs UVB: Comparable Psoriasis Outcomes?

Randomized study found no statistically significant differences in disease improvement between treatments over 8 weeks.

Paradoxical inflammatory switches during biologic therapy: a mechanistic framework, clinical algorithm, and pediatric illustrations

Biologics Commonly Used in Cutaneous Crohn's Disease

Retrospective multicenter cohort highlights genital-predominant presentation patterns and frequent combination therapy use in cutaneous Crohn's disease.